044 209 91 25 079 869 90 44
Merkliste
Die Merkliste ist leer.
Der Warenkorb ist leer.
Kostenloser Versand möglich
Kostenloser Versand möglich
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Precision Medicine, CRISPR, and Genome Engineering

Moving from Association to Biology and Therapeutics
BuchGebunden
Verkaufsrang79529inBiologie
CHF239.00

Beschreibung

This book presents descriptive overviews of gene editing strategies across multiple species while also offering in-depth insight on complex cases of application in the field of tissue engineering and regenerative medicine. Chapters feature contributions from leaders in stem cell therapy and biology, providing a comprehensive view of the application of gene therapy in numerous fields with an emphasis on ophthalmology, stem cells, and agriculture. The book also highlights recent major technological advances, including ZFN, TALEN, and CRISPR. Precision Medicine, CRISPR, and Genome Engineering is part of the highly successful Advances in Experimental Medicine and Biology series. It is an indispensable resource for researchers and students in genetics as well as clinicians.
Weitere Beschreibungen

Details

ISBN/GTIN978-3-319-63903-1
ProduktartBuch
EinbandGebunden
Erscheinungsdatum21.11.2017
Auflage1st ed. 2017
Reihen-Nr.1016
Seiten188 Seiten
SpracheEnglisch
MasseBreite 160 mm, Höhe 241 mm, Dicke 16 mm
Gewicht453 g
Artikel-Nr.30621484
Verlagsartikel-Nr.978-3-319-63903-1
KatalogBuchzentrum
Datenquelle-Nr.23614306
WarengruppeBiologie
Weitere Details

Reihe

Über den/die AutorIn

For years, Stephen Tsang has been culturing embryonic stem (ES) cells and created the first mouse model for a recessive form of retinitis pigmentosa by applying homologous recombination to ES cell technology. Two elements define his laboratory. First, by leveraging his genetics clinical practice, in which over 1000 retinal patients are cared for, he brings an array of clinical resources to his research, including stem cells and live imaging data. Second, he and his students are recognized authorities in a broad array of state-of-the-art technologies. Most recently, he was invited as a Moderator for the Gene Editing/Rewriting the Genome session during the 65th American Society of Human Genetics Annual Meeting.